Printer Friendly

GE buys microcalorimetry firm.

Chalfont St. Giles, England 9/30/08; Boston, MA 9/30/08--GE Healthcare has acquired MicroCal, a developer and manufacturer of microcalorimeters, for an undisclosed amount from majority owner Riverside Partners and other investors. MicroCal's 2008 revenues are estimated to be $28 million, up from $21 million in 2007, and have grown at more than 25% annually. According to GE, MicroCal's systems are used in more than one thousand labs. GE stated that microcalorimetry, which provides information about biomolecules' structure, function and binding properties, will expand its offerings for protein science and drug discovery and is complementary to the company's Biacore platform (see IBO 6/30/06). GE will develop MicroCal's facility in Northampton, Massachusetts, into a center for excellence for microcalorimetry. MicroCal CEO Richard Brown will remain with the company, which has 75 employees.

The acquisition makes GE Healthcare the leading provider of microcalorimetry for pharmaceutical applications, a market in which it competes against Waters" TA Instruments. The acquisition, like GE's purchase of Biacore, is an indication of the company's interest in niche technologqy markets for drug development.

COPYRIGHT 2008 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Executive Briefing: News & Views for Executives; General Electric Co. GE Healthcare
Publication:Instrument Business Outlook
Article Type:Brief article
Date:Sep 30, 2008
Previous Article:New R&D laboratories.
Next Article:Invitrogen announces post-merger structure.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters